264 related articles for article (PubMed ID: 3690290)
1. Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: implications regarding identification of brain structures involved in consolidation of memory traces.
Piercey MF; Vogelsang GD; Franklin SR; Tang AH
Brain Res; 1987 Oct; 424(1):1-9. PubMed ID: 3690290
[TBL] [Abstract][Full Text] [Related]
2. Effect of Piracetam on electrocorticogram and local cerebral glucose utilization in the rat.
Grau M; Montero JL; Balasch J
Gen Pharmacol; 1987; 18(2):205-11. PubMed ID: 3569848
[TBL] [Abstract][Full Text] [Related]
3. Specificity of piracetam's anti-amnesic activity in three models of amnesia in the mouse.
Lenègre A; Chermat R; Avril I; Stéru L; Porsolt RD
Pharmacol Biochem Behav; 1988 Mar; 29(3):625-9. PubMed ID: 3362958
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies on the effects of the nootropic drugs adafenoxate, meclofenoxate and piracetam, and of citicholine on scopolamine-impaired memory, exploratory behavior and physical capabilities (experiments on rats and mice).
Petkov VD; Mosharrof AH; Petkov VV
Acta Physiol Pharmacol Bulg; 1988; 14(1):3-13. PubMed ID: 3136617
[TBL] [Abstract][Full Text] [Related]
5. Gastrodin and p-hydroxybenzyl alcohol facilitate memory consolidation and retrieval, but not acquisition, on the passive avoidance task in rats.
Hsieh MT; Wu CR; Chen CF
J Ethnopharmacol; 1997 Mar; 56(1):45-54. PubMed ID: 9147253
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological restoration of scopolamine-impaired memory.
Petkov VV; Vuglenova Y
Acta Physiol Pharmacol Bulg; 1985; 11(3):37-43. PubMed ID: 3938594
[TBL] [Abstract][Full Text] [Related]
7. Reversal of scopolamine-induced alterations of choline transport across the blood-brain barrier by the nootropics piracetam and pramiracetam.
Brust P
Arzneimittelforschung; 1989 Oct; 39(10):1220-2. PubMed ID: 2610714
[TBL] [Abstract][Full Text] [Related]
8. Effects of oxiracetam on learning and memory in animals: comparison with piracetam.
Mondadori C; Classen W; Borkowski J; Ducret T; Buerki H; Schadé A
Clin Neuropharmacol; 1986; 9 Suppl 3():S27-38. PubMed ID: 3594453
[TBL] [Abstract][Full Text] [Related]
9. Effects of citicholine and of the combination citicholine + piracetam on the memory (experiments on mice).
Mosharrof AH; Petkov VD
Acta Physiol Pharmacol Bulg; 1990; 16(1):25-31. PubMed ID: 2392950
[TBL] [Abstract][Full Text] [Related]
10. Effect of piracetam and of standardized ginseng extract on the electroconvulsive shock-induced memory disturbances in "step-down" passive avoidance.
Lasarova MB; Mosharrof AH; Petkov VD; Markovska VL; Petkov VV
Acta Physiol Pharmacol Bulg; 1987; 13(2):11-7. PubMed ID: 3673597
[TBL] [Abstract][Full Text] [Related]
11. Effect of piracetam on electroshock induced amnesia and decrease in brain acetylcholine in rats.
Bhattacharya SK; Upadhyay SN; Jaiswal AK
Indian J Exp Biol; 1993 Oct; 31(10):822-4. PubMed ID: 8276434
[TBL] [Abstract][Full Text] [Related]
12. Brain neurotransmitter receptor binding and nootropic studies on Indian Hypericum perforatum Linn.
Kumar V; Khanna VK; Seth PK; Singh PN; Bhattacharya SK
Phytother Res; 2002 May; 16(3):210-6. PubMed ID: 12164263
[TBL] [Abstract][Full Text] [Related]
13. Nefiracetam (DM-9384) preserves hippocampal neural cell adhesion molecule-mediated memory consolidation processes during scopolamine disruption of passive avoidance training in the rat.
Doyle E; Regan CM; Shiotani T
J Neurochem; 1993 Jul; 61(1):266-72. PubMed ID: 8515273
[TBL] [Abstract][Full Text] [Related]
14. Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine.
Spignoli G; Pepeu G
Pharmacol Biochem Behav; 1987 Jul; 27(3):491-5. PubMed ID: 3659072
[TBL] [Abstract][Full Text] [Related]
15. Do piracetam-like compounds act centrally via peripheral mechanisms?
Mondadori C; Petschke F
Brain Res; 1987 Dec; 435(1-2):310-4. PubMed ID: 3427459
[TBL] [Abstract][Full Text] [Related]
16. Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents.
Cumin R; Bandle EF; Gamzu E; Haefely WE
Psychopharmacology (Berl); 1982; 78(2):104-11. PubMed ID: 6817363
[TBL] [Abstract][Full Text] [Related]
17. Avoidance facilitation by nootropics.
Sansone M; Oliverio A
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S89-97. PubMed ID: 2616794
[TBL] [Abstract][Full Text] [Related]
18. Effect of pyroglutamic acid stereoisomers on ECS and scopolamine-induced memory disruption and brain acetylcholine levels in the rat.
Spignoli G; Magnani M; Giovannini MG; Pepeu G
Pharmacol Res Commun; 1987 Dec; 19(12):901-12. PubMed ID: 3448611
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of memory disturbance during stages of memory acquisition and fixation.
Sprints AM
Neurosci Behav Physiol; 1989; 19(5):387-92. PubMed ID: 2615946
[TBL] [Abstract][Full Text] [Related]
20. Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats.
Chopin P; Briley M
Psychopharmacology (Berl); 1992; 106(1):26-30. PubMed ID: 1738791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
